Canton Strategic Holdings (CNTN)

• Market cap: $184M
• 1 day: 3.93%
• 5 days: -16.2%
• 1 month: -19.32%
• 3 months: -20.4%
• 6 months: -20.93%
• Year to date: -29.59%
• 1 year: 34.46%
• 5 years: -99.82%
• 10 years: -99.82%
• Sector: Healthcare
• Industry: Biotechnology

About: Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company operates in two reportable segments: digital asset treasury and clinical stage bio-technology. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.

Employees: 12